Skip to main content

Arbutus Biopharma Corp

ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001447028

No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Arbutus Biopharma Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
122
+9 vs. Q4 2022
Shares held
62.5M
+8.48M (+15.7%) vs. Q4 2022
Total value
$189.3M
+$63.4M (+50.4%) vs. Q4 2022
New holders
20
37 more added
Sold out
11
31 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ABUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 122 institutions
Q1 2021: 94 institutionsQ2 2021: 91 institutionsQ3 2021: 100 institutionsQ4 2021: 123 institutionsQ1 2022: 119 institutionsQ2 2022: 113 institutionsQ3 2022: 127 institutionsQ4 2022: 114 institutionsQ1 2023: 122 institutionsQ2 2023: 111 institutionsQ3 2023: 99 institutionsQ4 2023: 112 institutionsQ1 2024: 119 institutionsQ2 2024: 131 institutionsQ3 2024: 144 institutionsQ4 2024: 154 institutionsQ1 2025: 168 institutionsQ2 2025: 163 institutionsQ3 2025: 166 institutionsQ4 2025: 172 institutionsQ1 2026: 167 institutionsQ2 2026: 176 institutions
Value heldQ1 2023: $189.3M
Q1 2021: $86.5MQ2 2021: $87.6MQ3 2021: $149.8MQ4 2021: $154.4MQ1 2022: $130.6MQ2 2022: $120.0MQ3 2022: $89.1MQ4 2022: $126.3MQ1 2023: $189.3MQ2 2023: $152.4MQ3 2023: $143.8MQ4 2023: $197.4MQ1 2024: $215.2MQ2 2024: $298.4MQ3 2024: $389.2MQ4 2024: $340.3MQ1 2025: $390.1MQ2 2025: $365.0MQ3 2025: $536.4MQ4 2025: $586.9MQ1 2026: $625.4MQ2 2026: $674.9M
Institutions holding ABUS and their total value by quarter
QuarterHoldersValue
Q2 2026176$674.9M
Q1 2026167$625.4M
Q4 2025172$586.9M
Q3 2025166$536.4M
Q2 2025163$365.0M
Q1 2025168$390.1M
Q4 2024154$340.3M
Q3 2024144$389.2M
Q2 2024131$298.4M
Q1 2024119$215.2M
Q4 2023112$197.4M
Q3 202399$143.8M
Q2 2023111$152.4M
Q1 2023122$189.3M
Q4 2022114$126.3M
Q3 2022127$89.1M
Q2 2022113$120.0M
Q1 2022119$130.6M
Q4 2021123$154.4M
Q3 2021100$149.8M
Q2 202191$87.6M
Q1 202194$86.5M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Arbutus Biopharma Corp; share changes are against Q4 2022.

Institutions holding ABUS in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Charles Schwab Investment Management Inc308,969$936.2K0.00%+3,689+1.2%Added
Bank of Montreal317,455$981.2K0.00%−2,338−0.7%Reduced
Primecap Management Co345,900$1.05M0.00%−5,600−1.6%Reduced
Two Sigma Investments, LP369,777$1.12M0.00%+369,777New
Kennedy Capital Management, Inc.392,843$1.19M0.04%+392,843New
Bank of New York Mellon Corp422,681$1.28M0.00%+4,154+1.0%Added
Boothbay Fund Management, LLC623,987$1.89M0.05%−88,680−12.4%Reduced
Assenagon Asset Management S.A.817,574$2.48M0.01%00.0%Unchanged
Northern Trust Corp949,890$2.88M0.00%+31,149+3.4%Added
Advisor Group Holdings, Inc.1,376,523$4.17M0.01%00.0%Unchanged
Millennium Management LLC1,660,566$5.03M0.01%−192,149−10.4%Reduced
FourWorld Capital Management LLC2,000,090$6.06M3.80%00.0%Unchanged
State Street Corp2,068,052$6.27M0.00%+42,986+2.1%Added
Geode Capital Management, LLC2,287,913$6.93M0.00%+156,645+7.3%Added
Woodline Partners LP2,657,605$8.05M0.11%+2,657,605New
Hudson Bay Capital Management LP2,736,426$8.29M0.09%−2,114,990−43.6%Reduced
Rubric Capital Management LP4,195,072$12.7M0.51%+728,791+21.0%Added
Morgan Stanley4,882,607$14.8M0.00%+4,640,713+1,918.5%Added
Vanguard Group Inc5,641,202$17.1M0.00%+276,177+5.1%Added
Two Seas Capital LP7,464,724$22.6M20.76%−39,469−0.5%Reduced
Whitefort Capital Management, LP7,500,026$22.7M21.12%+3,649,257+94.8%Added
BlackRock Inc.8,464,086$25.6M0.00%−236,306−2.7%Reduced
Oasis Management Co Ltd.0$00.00%−1,088,895−100.0%Sold out
Jacob Asset Management of New York LLC0$00.00%−187,400−100.0%Sold out
Caption Management, LLC0$00.00%−50,000−100.0%Sold out
Man Group plc0$00.00%−44,900−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−14,633−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−13,630−100.0%Sold out
Squarepoint Ops LLC0$00.00%−13,650−100.0%Sold out
Alpine Global Management, LLC0$00.00%−10,198−100.0%Sold out
Zurcher Kantonalbank (Zurich Cantonalbank)0$00.00%−6,178−100.0%Sold out
Credit Suisse AG0$00.00%−1,102−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−1,000−100.0%Sold out
Kepos Capital LP––––Not filed